Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis

BackgroundImmune checkpoint inhibitors (ICIs) have demonstrated remarkable efficacy in non-small cell lung cancer (NSCLC). However, only a minority of NSCLC patients benefit from ICIs, and whether the magnitude of benefit is specific factor-dependent remains unclear. We performed a systematic review...

Full description

Bibliographic Details
Main Authors: Fang Yang, Yucai Wang, Lin Tang, Aaron Scott Mansfield, Alex A. Adjei, Konstantinos Leventakos, Narjust Duma, Jia Wei, Lifeng Wang, Baorui Liu, Julian R. Molina
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
immune checkpoint inhibitor
efficacy
survival
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.955440/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.955440/full

Similar Items